EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z · by effect 58 graded findings

Inflammation, joints and pain

What human research has studied for osteoarthritis, joint pain and inflammatory markers, across every ingredient in this guide, strongest evidence first. A grade describes the evidence, not a recommendation.

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. Ask a doctor or pharmacist before use, especially with medicines, in pregnancy or for a child.

Summary

How strong the evidence is

Show

Where inflammation, joints and pain sits on the supplement body map; colored by its strongest grade here.

Findings

Findings by ingredient

Inflammation, joints and pain: findings by ingredient and grade
IngredientGradeWhat was studied and found
BoswelliaBKnee and other osteoarthritis pain and function. Cochrane: two high-quality trials (85 people) of 100 mg/day enriched extract for 90 days cut pain by 17 points (0–100 scale) and improved function by 8 points versus placebo. sources
BromelainBPain and recovery after wisdom tooth (third molar) surgery. A 2019 meta-analysis (6 RCTs) found less pain in the first 24 hours and at 7 days and better quality-of-life scores, but no evidence that bromelain reduced trismus or facial swelling. sources
Collagen peptidesBKnee osteoarthritis pain and function. A 2025 meta-analysis of 11 RCTs (870 participants) found improved pain and function scores versus placebo, with high heterogeneity between trials (I² 75% and 88%). sources
Devil's clawBNon-specific low back pain in adults. A Cochrane review found that daily extracts standardized to 50 mg or 100 mg harpagoside may beat placebo for short-term pain and rescue-medication use (two trials, 315 participants, low-quality evidence). sources
GLA oils (borage and blackcurrant seed oil)BRheumatoid arthritis pain and disability. A 2011 Cochrane review pooled 7 studies of GLA from evening primrose, borage or blackcurrant seed oil: lower pain intensity (-32.83 points, 100-point scale) and less disability; authors judged the evidence moderate. sources
HesperidinBInflammation and oxidative stress markers. A 2026 meta-analysis of 10 RCTs (532 participants) found lower C-reactive protein (SMD -0.43) and TNF-α (SMD -0.51), but no significant effect on IL-6 overall. sources
MSM (methylsulfonylmethane)BKnee osteoarthritis pain and function. A 2018 meta-analysis of placebo-controlled RCTs of oral supplements found statistically significant improvements in osteoarthritis pain with MSM, but of unclear clinical importance. sources
N-acetylcysteine (NAC)BInflammatory markers in adults. A 2020 meta-analysis of 24 RCTs (1,057 participants; 400–2000 mg/day for 1–80 weeks) found oral NAC lowered CRP (−0.61 mg/L) and IL-6, with high heterogeneity; other inflammatory markers did not change. sources
Palmitoylethanolamide (PEA)BChronic pain. A 2023 meta-analysis of 11 double-blind RCTs (774 patients; 4 tested PEA with transpolydatin) found lower pain scores than comparators (SMD 1.68); no major side effects were attributed to PEA. sources
Palmitoylethanolamide (PEA)BAcute or chronic pain versus inactive control. A 2017 meta-analysis pooled 8 RCTs with inactive controls and found greater pain reduction with PEA; the authors note few trials, varied conditions and often poor study quality. sources
Rose hipBOsteoarthritis pain. A 2008 meta-analysis of three placebo-controlled RCTs (287 patients, median 3 months) found reduced pain (effect size 0.37), with patients about twice as likely to respond (OR 2.19); all trials were manufacturer-supported, and independent replication was called for. sources
Turmeric (and curcumin)BKnee osteoarthritis pain and function (oral). Several meta-analyses evaluated oral turmeric or curcumin; NCCIH calls the initial evidence positive but says higher-quality evidence is needed for definitive conclusions. sources
Undenatured type II collagenBKnee osteoarthritis pain and function. A 2023 review of 8 RCTs (3–6 months) pooled 6 for WOMAC (MD -8.91) and 3 for VAS pain (MD -1.65), both favoring the collagen over placebo or control; Lequesne index did not differ. Authors call for larger trials. sources
Undenatured type II collagenBKnee osteoarthritis (180-day trial versus placebo and glucosamine-chondroitin). In an RCT of 191 volunteers, 40 mg/day for 180 days reduced total WOMAC score versus placebo (p = 0.002) and versus glucosamine plus chondroitin (p = 0.04); safety outcomes did not differ among groups. sources
Undenatured type II collagenBOsteoarthritis pain across supplements (meta-analysis). A 2018 meta-analysis of 69 placebo-controlled RCTs of 20 supplements found only green-lipped mussel extract and undenatured type II collagen had clinically important effects on pain at medium term. sources
AndrographisCRheumatoid arthritis symptoms. Small trials suggested reduced rheumatoid factors and arthritis symptoms; MSK states additional studies are needed to confirm these effects. sources
Argan oilCKnee osteoarthritis symptoms. In one randomized trial of 100 patients with knee osteoarthritis, 30 ml/day of culinary argan oil for 8 weeks improved pain, function and walking distance versus no treatment; there was no placebo. sources
ArnicaCHand osteoarthritis pain (gel on the skin). In a double-blind RCT of 204 patients over 21 days, an arnica gel (50 g tincture/100 g) was not inferior to 5% ibuprofen gel for pain and hand function. sources
ArnicaCPain and inflammation (overall evidence). LiverTox states there is little evidence for efficacy of either oral homeopathic or topical herbal arnica, and clinical studies have not confirmed its effects on inflammation or pain. sources
Aronia (black chokeberry)CInflammation markers and antioxidant enzymes. A 2025 systematic review of 18 studies (aronia juice, extract or powder for 4 to 13 weeks) reported lower CRP, TNF-alpha and IL-6, higher IL-10 and higher antioxidant enzyme activity. sources
AçaíCMetabolic syndrome biomarkers. A 12-week double-blind trial in 37 adults with metabolic syndrome lowered two markers of inflammation and oxidative stress versus placebo, with no change in glucose or lipid metabolism; authors called it a weak indication. sources
Bacillus coagulans (Heyndrickxia coagulans)CRheumatoid arthritis, alongside standard medication (strain GBI-30, 6086). In a pilot RCT of 45 adults, 60 days of GBI-30, 6086 gave a borderline improvement in patient pain assessment (P = .052) and a significant pain-scale improvement versus placebo; authors call for larger trials. sources
Baikal skullcapCOsteoarthritis symptoms (multi-ingredient supplement). MSK reports that an herbal supplement containing S. baicalensis reduced osteoarthritis symptoms, but it is not known whether the herb alone would have similar effects. sources
Betaine (trimethylglycine)CInflammatory markers. A 2023 meta-analysis of 6 RCTs (277 participants) found a slight reduction in IL-1β with high heterogeneity and no significant change in CRP, IL-6 or TNF-α; the authors found insufficient evidence. sources
BoronCOsteoarthritis symptoms. Small trials (20–60 participants, 2–8 weeks, 1.5–12 mg/day) reported reduced symptoms or inflammatory markers; ODS says confirmation is needed from additional controlled trials. sources
BPC-157CChronic knee pain (injection into the joint). In a retrospective study of intra-articular BPC-157 injection for knee pain, 7 of 12 patients reported relief for more than 6 months; the 2025 review rated the available studies level IV and V evidence. sources
BromelainCPain (oral bromelain across conditions). A 2023 meta-analysis found pain reduction from oral bromelain slightly but significantly better than controls (mean difference -0.27; 9 studies); bromelain was not effective for cardiovascular diseases. sources
Carnosine (L-carnosine)CInflammation and oxidative stress markers. A 2024 meta-analysis of 9 trials (350 participants) of carnosine or other histidine-containing dipeptides found lower CRP, TNF-α and MDA but no effect on IL-6, adiponectin, GSH, SOD or TAC. sources
Cat's clawCRheumatoid arthritis (adults also taking sulfasalazine or hydroxychloroquine). A 24-week placebo-controlled trial in 40 patients found fewer painful joints with a pentacyclic-chemotype extract (53.2% vs 24.1% reduction); the authors called it a small preliminary study. sources
Cat's clawCKnee osteoarthritis (Uncaria guianensis). A 4-week trial in 45 patients (30 freeze-dried U. guianensis, 15 placebo) reported less pain with activity; knee pain at rest or at night did not change significantly. sources
Devil's clawCKnee and hip osteoarthritis. In a 4-month double-blind trial of 122 patients, powdered root was comparable to diacerhein 100 mg/day for pain and function, with less diarrhea; there was no placebo group. sources
Devil's clawCOsteoarthritis and back pain (systematic review). A 2004 review of 12 trials could not pool data; it rated evidence limited for low-harpagoside ethanolic extracts and moderate for powder at 60 mg harpagoside in osteoarthritis. sources
GingerCKnee osteoarthritis symptoms. Oral supplements might help, but much of the research is of poor quality; topical ginger has not been shown to help. sources
Glucosamine and chondroitinCKnee osteoarthritis pain and function. A 2018 analysis of 29 studies (6,120 participants) found pain reduced by glucosamine or chondroitin alone but not by the combination; individual studies were inconsistent, and NCCIH calls the benefit uncertain. sources
Glucosamine and chondroitinCJoint structure (joint-space narrowing) in knee osteoarthritis. Two large 2-year trials conflicted: an Australian trial (605 participants) found less narrowing with the combination; a US trial (572 participants) found no difference from placebo. sources
Glucosamine and chondroitinCHand osteoarthritis (chondroitin). One 6-month study in 162 participants found less hand pain and better function with chondroitin than placebo. sources
Glucosamine and chondroitinCTemporomandibular joint osteoarthritis (glucosamine). A review of 8 studies (538 participants) could not reach definite conclusions; studies differed in methods and products and some may have been biased. sources
HaritakiCKnee joint discomfort with activity in overweight adults. An 84-day RCT in 105 overweight, otherwise healthy adults found a standardized aqueous fruit extract (250 or 500 mg twice daily) improved knee-joint scores (mKOOS global) versus placebo. sources
Hyaluronic acid (oral)COsteoarthritis and low back pain. A 2024 systematic review of 11 trials (597 patients) found improvement in 9; only 2 trials gave oral hyaluronic acid alone, while 9 combined it with substances such as glucosamine, chondroitin or collagen. sources
Krill oilCKnee pain, stiffness and function. A 2024 meta-analysis (5 RCTs, 700 patients) found no significant difference from placebo for knee pain, stiffness or lipids, and a small improvement in knee physical function (SMD -0.24). sources
MSM (methylsulfonylmethane)CKnee pain during military training. In an RCT of 180 military trainees, 3 g/day for 8 weeks did not significantly improve knee outcome or mood scores versus placebo. sources
MSM (methylsulfonylmethane)CMild knee pain in healthy adults. In an RCT of 88 healthy Japanese adults with mild knee pain, 2 g/day (ten 200 mg tablets) for 12 weeks improved a knee quality-of-life score versus placebo (p = 0.046). sources
PerillaCExtract (var. frutescens): mild knee joint pain. In an 8-week RCT of 80 adults without radiographic arthritis, a 700 mg extract capsule twice daily reduced pain and WOMAC scores more than placebo; inflammation markers did not change. sources
PropolisCRheumatoid arthritis disease activity. MSK reports that a double-blind RCT of Brazilian propolis found no benefit for rheumatoid arthritis. sources
Rose hipCKnee function during walking. In one 12-week RCT of 100 adults with knee-related walking limitations, rose hip powder capsules improved the peak resultant knee moment during walking versus placebo (0.06 Nm/kg). sources
Rose hipCRheumatoid arthritis. In one 6-month RCT of 89 patients, 5 g/day rose hip powder improved a disability score (HAQ-DI) versus placebo; pain scores and pain-medication use did not differ. sources
SAMe (S-adenosyl-L-methionine)COsteoarthritis of the knee or hip. A 2009 Cochrane review (4 placebo-controlled trials, 656 patients) found a small, non-significant pain difference (0.4 cm on a 10 cm scale), called the evidence inconclusive and advised against routine use. sources
SerrapeptaseCTrismus, swelling and pain after impacted molar surgery. A 2018 meta-analysis (5 studies) found serratiopeptidase improved trismus more than corticosteroids (mean difference 4.42) with no difference in swelling; too few studies allowed conclusions on other outcomes or comparators. sources
SerrapeptaseCAnti-inflammatory and pain-relief use overall. A 2013 systematic review (24 clinical studies) found the evidence rests on studies of poor methodology, with only a few small, usually placebo-controlled RCTs, and judged it insufficient to support use as an analgesic or health supplement. sources
SpearmintCKnee osteoarthritis pain. In a 16-week randomized trial (62 enrolled), high-rosmarinic-acid spearmint tea reduced pain from baseline but a commercial spearmint tea did not; both teas improved stiffness and physical disability. sources
Sweet wormwoodCHip and knee osteoarthritis pain. Pilot RCT (42 patients, 12 weeks): 150 mg extract twice daily improved WOMAC and pain scores from baseline; 300 mg twice daily and placebo did not. Authors called for further studies. sources
TocotrienolsCInflammation and oxidative-stress markers. A 2021 meta-analysis (19 RCTs reviewed, 13 pooled) found lower CRP, attributed to a single delta-tocotrienol study, and no effect on IL-6, TNF-alpha or malondialdehyde. sources
Turmeric (and curcumin)CKnee osteoarthritis pain (topical ointment). NCCIH states it is unclear whether topical curcumin ointment affects knee osteoarthritis pain. sources
Undenatured type II collagenCExercise-related knee discomfort in healthy adults. In an RCT of 55 healthy adults, 40 mg/day for 120 days improved knee extension versus placebo (81.0° vs 74.0°; p = 0.011); time exercised before joint discomfort lengthened versus baseline. sources
Undenatured type II collagenCKnee flexibility in healthy adults with activity-related joint discomfort. In a multicenter RCT of 96 adults, 40 mg/day for 24 weeks increased knee flexion range of motion versus placebo (3.23° vs 0.21°; p = 0.025). sources
Undenatured type II collagenCJoint function in healthy adults with activity-related discomfort (180 days). In an RCT of 74 healthy adults, KOOS joint-function scores improved in both the native type II collagen and placebo groups by day 180; improvements from baseline appeared earlier with the collagen. sources
ChagaDInflammation and pain. Anti-inflammatory effects were seen in colitis models in mice, and pain-relieving effects in cell and animal studies; not studied in people. sources
Glucosamine and chondroitinXHip osteoarthritis (glucosamine sulfate). A 2-year trial in 222 participants found glucosamine sulfate no better than placebo for pain, function or joint-space narrowing. sources
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

All effect categories · All entries A–Z · Interactions

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.